Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Overview of attention for article published in BMC Cancer, September 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 352 followers.

RT @OLichius: Treatment of recurrent/metastatic #headandneckcancer is a challenge. This prospective, multi-center trial in unselected patie…

03 Oct 2020

Reply Repost Favourite

Treatment of recurrent/metastatic #headandneckcancer is a challenge. This prospective, multi-center trial in unselected patients shows in real word data that treatment response lowers tumor symptom burden with important impact on #qualitylife: https://t.co

03 Oct 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.